Published in Circulation on November 03, 2015
Biomarkers in Pediatric Congenital Heart Disease and PAH | NCT04130243
A Biobank for Long-term and Sustainable Research in the Field of Congenital Heart Disease in Germany. Genomics Proteomics Bioinformatics (2016) 0.81
High throughput physiological screening of iPSC-derived cardiomyocytes for drug development. Biochim Biophys Acta (2016) 0.80
World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology. Cardiol Clin (2016) 0.75
Effects of Ganoderma Lucidum shell-broken spore on oxidative stress of the rabbit urinary bladder using an in vivo model of ischemia/reperfusion. Mol Cell Biochem (2017) 0.75
Effect of α7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature (2007) 4.63
Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA (2007) 4.27
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation (2004) 3.51
Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation (2010) 3.13
Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation (2009) 2.73
MicroRNA regulation of cardiovascular development. Circ Res (2009) 2.42
Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant (1996) 1.94
Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg (1997) 1.75
Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail (2011) 1.72
GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. Circulation (2012) 1.71
Taking microRNAs to heart. Trends Mol Med (2008) 1.69
MicroRNAs and their roles in aging. J Cell Sci (2012) 1.60
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med (2014) 1.59
Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation (2012) 1.54
Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart (2008) 1.52
A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young (2007) 1.48
Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle. Cardiovasc Res (2004) 1.43
Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol (2001) 1.40
Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation (2013) 1.35
Abnormalities of sodium and H2O handling in chronic obstructive lung disease. Arch Intern Med (1982) 1.35
Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res (2007) 1.33
Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation (1992) 1.30
Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. J Mol Med (Berl) (2010) 1.25
Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail (2012) 1.23
Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics (2005) 1.22
Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J Physiol (2005) 1.17
A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. J Thorac Cardiovasc Surg (2008) 1.15
Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol (2008) 1.14
Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. Am J Physiol Heart Circ Physiol (2010) 1.13
MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat (2011) 1.11
Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol (1998) 1.10
Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation (2005) 1.07
MiR-148a inhibits angiogenesis by targeting ERBB3. J Biomed Res (2011) 1.06
Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol (2008) 1.05
Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics (2012) 1.05
MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond) (2012) 1.05
Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol (2006) 1.05
Right versus left ventricular failure: differences, similarities, and interactions. Circulation (2014) 1.04
Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J (1998) 1.03
Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure. Am J Physiol Heart Circ Physiol (2008) 1.03
The ventricular septum: the lion of right ventricular function, and its impact on right ventricular restoration. Eur J Cardiothorac Surg (2006) 1.03
Mechanisms of oxygen demand/supply balance in the right ventricle. Exp Biol Med (Maywood) (2005) 1.02
A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension. Circ Res (2014) 0.95
Determinants of right ventricular afterload (2013 Grover Conference series). Pulm Circ (2014) 0.95
Right and left ventricular oxygen metabolism in open-chest dogs. Am J Physiol (1982) 0.94
Role of nitric oxide and adenosine in control of coronary blood flow in exercising dogs. Circulation (2000) 0.94
Genomic profiling of left and right ventricular hypertrophy in congenital heart disease. J Card Fail (2008) 0.93
Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: In vivo and ex vivo correlation in human subjects. Magn Reson Med (2011) 0.92
Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study. Heart Vessels (2009) 0.91
Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. Cardiovasc Res (2001) 0.90
The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis (2005) 0.89
Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am J Physiol Heart Circ Physiol (2010) 0.88
Homogenous protein programming in the mammalian left and right ventricle free walls. Physiol Genomics (2011) 0.86
Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol (2011) 0.85
Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive. Am J Physiol Heart Circ Physiol (2009) 0.85
Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope. Eur J Heart Fail (2009) 0.85
Microvascular development in porcine right and left ventricular walls. Pediatr Res (2007) 0.85
Energy metabolism in normal and hypertrophied right ventricle of the ferret heart. J Mol Cell Cardiol (1997) 0.85
The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ (2014) 0.84
Right coronary autoregulation in conscious, chronically instrumented dogs. Am J Physiol (1998) 0.84
The activation pattern of the antioxidant enzymes in the right ventricle of rat in response to pressure overload is of heart failure type. Heart Dis (2003) 0.84
Common microRNA signatures in cardiac hypertrophic and atrophic remodeling induced by changes in hemodynamic load. PLoS One (2010) 0.84
Oxygen metabolism of the hypertrophic right ventricle in open chest dogs. Cardiovasc Res (1991) 0.83
Physiologic and molecular characterization of a murine model of right ventricular volume overload. Am J Physiol Heart Circ Physiol (2013) 0.83
Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol (2007) 0.83
Myocardial hypertrophy overrides the angiogenic response to hypoxia. PLoS One (2008) 0.83
Iloprost reverses established fibrosis in experimental right ventricular failure. Eur Respir J (2014) 0.80
MicroRNAs in right ventricular (dys)function (2013 Grover Conference series). Pulm Circ (2014) 0.79
Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol (2003) 0.79
Recent progress in the molecular genetics of congenital heart defects. Clin Genet (1998) 0.78
Therapeutic options for systemic right ventricular failure. Heart (2009) 0.78
Contribution of afterload, hypertrophy and geometry to left ventricular ejection fraction in aortic valve stenosis, pure aortic regurgitation and idiopathic dilated cardiomyopathy. Am J Cardiol (1987) 0.77
Right ventricular infundibular beta-adrenoceptor complex in tetralogy of Fallot patients. Pediatr Res (1997) 0.76
Identification of differently expressed genes and small molecule drugs for Tetralogy of Fallot by bioinformatics strategy. Pediatr Cardiol (2014) 0.76